# Sow Good Inc.: overview SOWG · Nasdaq · CIK 1490161 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sowg.md) · [Financials](/companies/sowg/financials.md) · [Filings](/companies/sowg/filings.md) · [Insiders](/companies/sowg/insiders.md) Latest reported revenue: [−$5.9m](/filings/0001193125-26-133385.md) for Q4 FY2025, three months to 2025-12-31, from the 10-K filed Mar 31, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-133385). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [3.6](/filings/0001193125-25-281675.md) | [(30.6) d](/filings/0001193125-26-133385.md) | [2.5](/filings/0000950170-25-070957.md) | [1.9](/filings/0000950170-25-108449.md) | [1.6](/filings/0001193125-25-281675.md) | [(5.9) d](/filings/0001193125-26-133385.md) | not reported | not reported | | Gross margin | % | [15.6%](/filings/0001193125-25-281675.md) | [4.0% d](/filings/0000950170-25-045749.md) | [44.5%](/filings/0000950170-25-070957.md) | [(7.0%)](/filings/0000950170-25-108449.md) | [(576.1%)](/filings/0001193125-25-281675.md) | not reported | not reported | not reported | | Operating margin | % | [(91.6%)](/filings/0001193125-25-281675.md) | [44.6% d](/filings/0001193125-26-133385.md) | [(64.0%)](/filings/0001213900-26-059638.md) | [(62.4%)](/filings/0001213900-26-091752.md) | [(812.4%)](/filings/0001193125-25-281675.md) | [(212.4%) d](/filings/0001193125-26-133385.md) | not reported | not reported | | Net margin | % | [(95.1%)](/filings/0001193125-25-281675.md) | [13.6% d](/filings/0001193125-26-133385.md) | [(111.2%)](/filings/0001213900-26-059638.md) | [(225.5%)](/filings/0001213900-26-091752.md) | [(704.1%)](/filings/0001193125-25-281675.md) | [389.9% d](/filings/0001193125-26-133385.md) | not reported | not reported | | Diluted EPS | $ per share | [(0.33)](/filings/0001193125-25-281675.md) | not reported | [(3.40)](/filings/0001213900-26-059638.md) | [(5.43)](/filings/0001213900-26-091752.md) | [(0.90)](/filings/0001193125-25-281675.md) | not reported | [(0.13)](/filings/0001213900-26-059638.md) | [(0.19)](/filings/0001213900-26-091752.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001683168-23-002404.md) | [0.4](/filings/0001437749-24-009065.md) | [16.1](/filings/0000950170-25-045749.md) | [0.0](/filings/0001193125-26-133385.md) | [0.0](/filings/0001193125-26-133385.md) | | Gross margin | % | [8.1%](/filings/0001683168-23-002404.md) | [28.0%](/filings/0001437749-24-009065.md) | [20.4%](/filings/0000950170-25-045749.md) | not reported | not reported | | Operating margin | % | [(8037.0%)](/filings/0001683168-23-002404.md) | [(2542.6%)](/filings/0001437749-24-009065.md) | [(7.6%)](/filings/0000950170-25-045749.md) | not reported | not reported | | Net margin | % | [(7772.7%)](/filings/0001683168-23-002404.md) | [(2832.6%)](/filings/0001437749-24-009065.md) | [(19.0%)](/filings/0000950170-25-045749.md) | not reported | not reported | | Diluted EPS | $ per share | [(1.61)](/filings/0001683168-23-002404.md) | [(2.51)](/filings/0001683168-23-002404.md) | [(0.59)](/filings/0000950170-25-045749.md) | [(0.40)](/filings/0001193125-26-133385.md) | [(3.44)](/filings/0001193125-26-133385.md) | | Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sowg/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $946.5k | 226,970 | | New +226,970 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $785.8k | 188,440 | | New +188,440 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $433.7k | 103,997 | | New +103,997 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $298.4k | 71,562 | | New +71,562 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $179.5k | 43,042 | | New +43,042 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $80.8k | 19,380 | | New +19,380 | | [Connective Capital Management, LLC](/funds/1543568.md) | 2026-06-30 | $51.5k | 12,354 | | New +12,354 | | [IFP Advisors, Inc](/funds/1641866.md) | 2026-06-30 | $1.8k | 434 | | New +434 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $4 | 1 | | New +1 | | [Caitong International Asset Management Co., Ltd](/funds/1963355.md) | 2026-06-30 | $4 | 1 | | New +1 | ## Recent filings [All 650 filings](/companies/sowg/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-30 | 16:30 ET | [8-K](/filings/0001829126-26-011835.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-011835 | | 2026-10-15 | 16:15 ET | [8-K](/filings/0001829126-26-011186.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-011186 | | 2026-10-13 | 16:15 ET | [8-K](/filings/0001829126-26-011076.md) | 8.01 Other events | 0001829126-26-011076 | | 2026-08-27 | 16:40 ET | [8-K](/filings/0001829126-26-009427.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001829126-26-009427 | | 2026-08-19 | 17:03 ET | [10-Q](/filings/0001213900-26-091752.md) | Quarterly report, period 2026-06-30 | 0001213900-26-091752 | | 2026-08-10 | 16:30 ET | [8-K](/filings/0001829126-26-008533.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001829126-26-008533 | | 2026-07-27 | 16:30 ET | [DEF 14A](/filings/0001829126-26-007885.md) | Proxy statement, period 2026-08-10 | 0001829126-26-007885 | | 2026-05-20 | 17:17 ET | [10-Q](/filings/0001213900-26-059638.md) | Quarterly report, period 2026-03-31 | 0001213900-26-059638 | | 2026-05-11 | 07:30 ET | [8-K](/filings/0001829126-26-004890.md) | 5.02 Departure or appointment of officers or directors | 0001829126-26-004890 | | 2026-05-05 | 07:30 ET | [8-K](/filings/0001829126-26-004525.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001829126-26-004525 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-133385.md), filed Mar 31, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1490161 - Tickers: SOWG - Exchange: Nasdaq - SIC code: 2000 Food and Kindred Products - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:40 ET. No prices; not investment advice.